- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TN-20-0046506

Bageo Pharmaceuticals Private Limited
About Bageo Pharmaceuticals Private Limited
Data last updated:
Bageo Pharmaceuticals Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 24 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74999TZ2019PTC031589. Its GSTIN is 33AAICB2405M1ZU (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandran Sathishkumar and Suriyan Chandrasekar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No: 6/10 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.24 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹4.44 Lakh (net margin 3.6%) and EBITDA of ₹11.01 Lakh (EBITDA margin 8.9%).
Bageo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-20-0046506). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Bageo Pharmaceuticals
Contact details
Bageo Pharmaceuticals Private Limited's registered office is in Salem, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressShop No: 6/10 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Bageo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bageo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bageo Pharmaceuticals Private Limited, buy the company report.
Financials of Bageo Pharmaceuticals Private Limited
FY 2022 filings availableBageo Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (up 45% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 45% in the latest year. EBITDA rose 113% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹11.01 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.44 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.9% | |||
| Net Profit Margin | 3.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bageo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bageo Pharmaceuticals Private Limited
Bageo Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandran Sathishkumar | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
| Suriyan Chandrasekar | Director | 24 Jan 2019 | 7 Years 9 Months | Current |
| Mohammed Abdul Salam Mohamed Abdul Rahim | Director | 24 Jan 2019 | 7 Years 9 Months | Current |
| Balachandar Chinnasamy | Director | 24 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Bageo Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zoydec Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 19.0% | Chandigarh, India | |||
| Revanex Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 187.0% | Siliguri, West Bengal, India | |||
| Bageo Pharmaceuticals Private Limitedthis company | ₹1.24 Cr (FY 2022) | ₹4.44 Lakh | 3.6% | 45.0% | Salem, Tamil Nadu, India | |
| Arushnova Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 37.0% | Lucknow, Uttar Pradesh, India | |||
| Greatlee Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 7.0% | Sanand, Gujarat, India |
To see the full peer comparison of Bageo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bageo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bageo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bageo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICB2405M1ZU | Tamil Nadu | Active | 28 Feb 2019 |
To see the full GST registrations and return filing status of Bageo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bageo Pharmaceuticals Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Gunabalan Senthil Kumar ceased to be Director on 28 Nov 2022.
Frequently asked questions
Bageo Pharmaceuticals is an active private limited company based in Salem, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 24 January 2019 (7+ years old) and is registered under CIN U74999TZ2019PTC031589.
Bageo Pharmaceuticals has 4 current directors:
- Chandran Sathishkumar - Director
- Suriyan Chandrasekar - Director
- Mohammed Abdul Salam Mohamed Abdul Rahim - Director
- Balachandar Chinnasamy - Director
The latest financial statements of Bageo Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Bageo Pharmaceuticals is 33AAICB2405M1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Bageo Pharmaceuticals is U74999TZ2019PTC031589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bageo Pharmaceuticals was incorporated on 24 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Bageo Pharmaceuticals by revenue are Zoydec Pharmaceuticals Private Limited, Revanex Pharmaceuticals Private Limited, Arushnova Pharmaceuticals Private Limited, Greatlee Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gunabalan Senthil Kumar ceased to be Director on 28 Nov 2022. Chandran Sathishkumar was appointed as Director on 30 Nov 2021. Balachandar Chinnasamy was appointed as Director on 24 Jan 2019. Bageo Pharmaceuticals has 5 board changes on record in total.
Yes, Bageo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-20-0046506).
The registered office of Bageo Pharmaceuticals is at Shop No: 610 Senthil Complex Chinnathiruppathy Salem – 636008, Tamil Nadu, India – 636008.
Bageo Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.

